Abstract:Purpose Angiogenesis is an indispensable process during tumor development. The currently accepted standard method for quantifying tumor angiogenesis is to assess microvessel density (MVD) based on CD105 staining, which is an independent prognostic factor for survival in patients with most solid tumor types. The goal of this study is to evaluate tumor angiogenesis in a mouse model by near-infrared fluorescence (NIRF) imaging of CD105 expression. Methods TRC105, a human/murine chimeric anti-CD105 monoclonal antibody, was conjugated to an NIRF dye (IRDye 800CW; Ex: 778 nm; Em: 806 nm). FACS analysis and microscopy studies were performed to compare the CD105 binding affinity of TRC105 and 800CW-TRC105. In vivo/ex vivo NIRF imaging, blocking studies, and ex vivo histology were performed on 4T1 murine breast tumor-bearing mice to evaluate the ability of 800CW-TRC105 to target tumor angiogenesis. Another chimeric antibody, cetuximab, was used as an isotype-matched control. Results FACS analysis of human umbilical vein endothelial cells (HUVECs) revealed no difference in CD105 binding affinity between TRC105 and 800CW-TRC105, which was further validated by fluorescence microscopy. 800CW conjugation of TRC105 was achieved in excellent yield (> 85%), with an average of 0.4 800CW molecules per TRC105. Serial NIRF imaging after intravenous injection of 800CW-TRC105 revealed that the 4T1 tumor could be clearly visualized as early as 30 min post-injection. Quantitative region of interest (ROI) analysis showed that the tumor uptake peaked at about 16 h post-injection. Based on ex vivo NIRF imaging at 48 h post-injection, tumor uptake of 800CW-TRC105 was higher than most organs, thus providing excellent tumor contrast. Blocking experiments, control studies with 800CW-cetuximab and 800CW, as well as ex vivo histology all confirmed the in vivo target specificity of 800CW-TRC105. Conclusion This is the first successful NIRF imaging study of CD105 expression in vivo. Fast, prominent, persistent, and CD105-specific uptake of the probe during tumor angiogenesis was observed in a mouse model. 800CW-TRC105 may be used in the clinic for imaging tumor angiogenesis within the lesions close to the skin surface, tissues accessible by endoscopy, or during image-guided surgery.

Noninvasive De Novo Imaging Of Human Embryonic Stem Cell-Derived Teratoma Formation

Data from Noninvasive <i>De novo</i> Imaging of Human Embryonic Stem Cell–Derived Teratoma Formation

Bioluminescence Reporter Gene Imaging Characterize Human Embryonic Stem Cell-Derived Teratoma Formation

99mTc-3PRGD2 SPECT/CT allows noninvasive detection of human induced pluripotent stem cell (hiPSC)-derived teratoma

Molecular Imaging of Tumor Angiogenesis Using Rgd-Labeled Iron Oxide Nanoparticles

Noninvasive Detection of Human-Induced Pluripotent Stem Cell (Hipsc)-Derived Teratoma with an Integrin-Targeting Agent (99M)tc-3Prgd2.

Supplementary Figure 1 from Noninvasive De Novo Imaging of Human Embryonic Stem Cell–Derived Teratoma Formation

In vivo molecular MRI of cell survival and teratoma formation following embryonic stem cell transplantation into the injured murine myocardium.

In Vivo Gamma Imaging of the Secondary Tumors of Transplanted Human Fetal Striatum Neural Stem Cells-Derived Primary Tumor Cells.

Non-Invasive Imaging Of Endothelial Progenitor Cells In Tumor Neovascularization Using A Novel Dual-Modality Paramagnetic/Near-Infrared Fluorescence Probe

Imaging integrin αvβ3 positive glioma with a novel RGD dimer probe and the impact of antiangiogenic agent (Endostar) on its tumor uptake

Molecular Imaging for Assessment of Mesenchymal Stem Cells Mediated Breast Cancer Therapy.

DiR-labeled Embryonic Stem Cells for Targeted Imaging of in Vivo Gastric Cancer Cells

Imaging of 99Tcm-Labeled New Cyclic RGDfK Dimer in Nude Mice Bearing U87MG Human Glioma Xenografts

In Vivo Near-Infrared Fluorescence Imaging of CD105 Expression During Tumor Angiogenesis

Multichannel-optical imaging for in vivo evaluating the safety and therapeutic efficacy of stem cells in tumor model in terms of cell tropism, proliferation and NF-κB activity

Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.

Noninvasive Imaging of Tumor Integrin Expression Using 18 F-labeled RGD Dimer Peptide with PEG 4 Linkers

Evaluating the Effects of an Angiogenesis Inhibitor of Endostar with a Novel RGD Dimer Probe Labeled by 99Tcm

Imaging of Human Mesenchymal Stromal Cells: Homing to Human Brain Tumors

Molecular imaging for tracking transplanted embryonic stem cells in the treatment of acute liver injury